Should You Buy Standard Biotools Inc (LAB) Stock on Tuesday?

Overall market sentiment has been down on Standard Biotools Inc (LAB) stock lately. LAB receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Standard Biotools Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on LAB!

See Full LAB Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With LAB Stock Today?

Standard Biotools Inc (LAB) stock is trading at $1.78 as of 9:49 AM on Tuesday, Oct 10, a drop of -$0.02, or -1.39% from the previous closing price of $1.80. The stock has traded between $1.71 and $1.78 so far today. Volume today is less active than usual. So far 46,228 shares have traded compared to average volume of 559,647 shares.

More About Standard Biotools Inc

Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. Its segments include Proteomics and Genomics. Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. It provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company distributes its systems through its direct sales force and support organizations. Click Here to get the full Stock Report for Standard Biotools Inc stock.